Phase 1b, Partial-Blind, Parallel Group, Randomized Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine (DENVax) Administered Intradermally Using Needle or a Needle-Free PharmaJet Injector in Healthy Adults

Project: Other project

StatusFinished
Effective start/end date12/31/1212/14/16

Funding

  • Takeda Vaccines Inc: $214,256.00